Genetic Testing | Personalized Treatments | GeneSight

What is the GeneSight^® Psychotropic test?

If your patients are suffering from depression, medication trials can be frustrating and leave patients feeling worse. By analyzing clinically important genetic variations that may affect your patient’s response to psychiatric medications, the GeneSight^® Psychotropic test provides information that can help guide your medication selection.

How Much Does It Cost?

Regardless of income, we believe everyone should have access to the best possible care. That’s why we work directly with your patients to make sure our services are accessible and out-of-pocket costs are transparent.

1

people have taken the GeneSight test

1

clinical studies published in peer-reviewed journals. GeneSight Psychotropic is the only psychiatric pharmacogenomic test backed by such extensive research.

Learn More about GeneSight^® Testing.

Please let us know how we can help by filling out the form below.

#submit_button {display:none; } To submit this form it is necessary to enable Javascript and refresh the page.

Take the Next Step - PD

I Am A...

First Name

Last Name

Date of Birth (MM/DD/YYYY)

Email

Zip Code

Phone

Do You Have Clinician Information?

Clinic Name

Clinic Zip

Clinic Phone

Would you like to provide the patient's information?

Relationship to Patient

Patient First Name

Patient Last Name

Patient Zip Code

Patient Date of Birth (MM/DD/YYYY)

Are you interested in us contacting the patients' clinician about GeneSight?

Patient's Doctor's First Name

Patient's Doctor's Last Name

Patient's Clinic Name

Patient's Clinic Zip

Patient's Clinic Phone

NPI

Job Title

Would you like to provide information for the prescribing clinician?

Prescribing Clinician First Name

Prescribing Clinician Last Name

Prescribing Clinician NPI

How Can We Help You?

Do you live in the United States?

We would love to communicate with you about our programs, products, and services. We will always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. Your consent may be withdrawn at any time using the unsubscribe link provided in all of Myriad’s email communications.

Yes please, I would like to hear about programs, products, and services. No thanks, I do not want to hear about programs, products, and services.

How can we help?

Contact Information

By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Depression Treatment” landing page you agree to the possible transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be utilized for the sole purpose it was submitted for and governed by our Privacy Notice.

Largest Depression Pharmacogenomic Clinical Study Ever Demonstrates GeneSight Psychotropic Test Efficacy

as Published in the Journal of Psychiatric Research

Four Simple Steps to Order the GeneSight Test

The GeneSight^® test is administered in your office.

Step 1

Collect a DNA sample by painlessly swabbing the inside of your patient’s cheek.

Step 2

The sample is sent to our lab for analysis.

Step 3

In about 36 hours, your patient’s report is available for review.

Step 4

Guided by insights from your patient’s report, you can inform on medication selection.

Healthcare Provider Perspectives

See what happens when the GeneSight^® test becomes part of a clinician’s practice.

The GUIDED Study: The GeneSight Test Works
Dr. Gus Alva believes this type of pharmacogenomic testing should be a standard of care.

James Greer, M.D.
“I was immediately dumbstruck by what a difference GeneSight made in my ability to understand why patients had not gotten better.”

GUIDED Study: Improvement for Those Who Need It Most
“When using the GeneSight test to help patients, response, remission, and symptom improvement rates skyrocket.”